Somatic genomic testing is increasingly common in metastatic #BreastCancer What does it mean for patient care, outcomes, & perceptions? Our prospective decision analysis study – just out in in time for #SABCS19! 1/
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions